CLINICAL_TRIALS
trial_result
· 2014-02-07
Clinical Trial Update: A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia [Phase 4]
Summary
A Phase 4 postmarketing trial evaluating Xuezhikang Capsule for dyslipidemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China Academy of Chinese Medical Sciences | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED